Anxiolytic and sedative effects of essential oil from Casimiroa pringlei on Wistar rats

Journal of Medicinal Plants Research

Volumn 3, Issue 10, 2009, Pages 791-798

  Landaverde, N A ^a   Juarez Flores B I ^b   Jimenez Capdeville M E ^a   Ortiz Perez M D ^a  

^a UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

Author keywords

Anxiolytics; Casimiroa pringlei; Sedatives

Indexed keywords

ANXIOLYTIC AGENT; BROMAZEPAM; CAFFEINE; CASIMIROA PRINGLEI EXTRACT; ESSENTIAL OIL; PLANT EXTRACT; SEDATIVE AGENT; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CASIMIROA; CASIMIROA PRINGLEI; CONTROLLED STUDY; DOSE RESPONSE; DRUG ISOLATION; LD 50; MALE; MAZE TEST; NONHUMAN; OPEN FIELD BEHAVIOR; PLANT LEAF; RAT; SEDATION; SENSORIMOTOR FUNCTION; TRANQUILIZING ACTIVITY;

ANIMALIA; CASIMIROA; RATTUS; RATTUS NORVEGICUS; RUTACEAE;

EID: 73449102490     PISSN: 19960875     EISSN: 19960875     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Aguilar A, Camacho JR, Chino S, Jácquez P, López ME (1994). Herbario medicinal del Instituto Mexicano del Seguro Social. Información Etnobotánica. Instituto Mexicano del Seguro Social, México p. 218.
2. Akhondzadh S, Naghavi HR, Vazirian M, Shayeganpour A, Rashidi H, Khani M (2001). Passionflower in the treatment of generalized anxiety: A pilot double-blind randomized controlled trial with oxazepam. J. Clin. Pharm. Ther. 26: 363-367.
3. Argueta A, Cano, Cano L, Rodarte M (1994). Atlas de las Plantas de la Medicina Tradicional Mexicana. Instituto Nacional Indigenista, México. p 1193.
4. Bhattacharya SK, Satyan KS, Chakrabarti A (1997). Anxiogenic action of caffeine: An experimental study in rats. J. Psychopharm. 11: 219-224.
5. Bland M (2000). An introduction to Medical Statistics. Oxford Medical Publications. Second edition. United Kingdom p.410.
6. Bourin M, Hascoet M, Mansouri B, Colombel MC, Bradwejn J (1992). Comparison of behavioral effects after single and repeated administrations of four benzodiazepines in three mice behavioral models. J. Psychiatry Neurosci. 17: 72-77.
7. Carvalho-Freitas RM, Costa M (2002). Anxiolytic and sedative effects of extracts and essential oil from Citrus aurantium L. Biol. Pharmacol. Bull. 25: 1629-1633.
8. Carvalho-Netto EF, Nunes-de Souza RL (2004). Use of the elevated T-maze to study anxiety in mice. Behav. Brain Res. 148: 119-132.
9. Crawley JN (1985). Exploratory behavior models of anxiety in mice. Neurosci Bio. Behave. 9: 37-44.
10. da Silva LA, Elisabetsky E (2001). Interference of propilene glicol with the hole-board test. Braz. J. Med. Biol. Res. 34: 545-547.
11. Déciga-Campos M, Palacios-Espinoza JF, Reyes-Ramírez A, Mata R (2004). Antinociceptive and anti-inflamatory effects of compounds isolated from Scaphyglottis lívida and Maxillaria densa. J. Etnopharmacol. 114(2): 161-169.
12. Emamghoreishi M, Khasaki M, Aazam MF (2005). Coriandrum sativum: evaluation of its anxiolytic effect in the elevated plus-maze. J. Etnopharmacol. 96(3): 365-370.
13. Franck CL (1992). Toxicología Básica, Riesgos por exposición a sustancias tóxicas. Editorial Harla EUA. pp. 103-104.
14. Garzón MP, García-López PM, García EJ, Navarro-Ruíz A, Villanueva-Michel T, Villareal-de Puga LM, Casillas-Ochoa J (1999). Casimiroa edulis seed extracts show anticonvulsive properties in rats. J. Ethnopharmacol. 68: 275-282.
15. Guidelines for the Care and Use of Mammals in Neuroscience and Behavioral Research. (2003). National Research Council of the National Academies. The National Academies Press, Washington D.C.
16. Guidelines for the testing of chemicals, acute oral toxicity method (2000). Organisation for Economic Co-Operation and Development. Paris France.
17. Herrera-Ruiz M, González.Cortazar M, Jiménez-Ferrer E, Zamilpa A, Álvarez L, Ramírez G, Tortoriello J (2007). Anxiolytic effect of natural galphimines from Galphimia glauca and their chemical derivates. J. Nat. Prod. 70(12): 2054.
18. Irwin S (1962). Drug screening and evaluative procedures. Science 136: 123-128.
19. Jaffary F, Ghannadi A, Siahpoush A (2004). Antinociceptive effects of the hydroalcoholic extract and essential oil of Zataria multiflora. Fitoterapia 75(2): 217-220
20. Kalueff AV, Tuohimaa P (2004). Experimental modeling of anxiety and depression. Acta Neurobiol. Exp. 64: 439-448.
21. Komiya M, Takeuchi T, Harada E (2006). Lemon oil vapor causes an anti-stress effect via modulating the 5-HT and DA activities in mice. Behav. Brain Res. 172: 240-249.
22. Lister RG (1987). The use of a plus-maze to measure anxiety in the mouse. Psychopharmacol. 92: 180-185.
23. Litchfield JT, Wilcoxon FJ (1949). Method of Litchfield and Wilcoxon: Confidence limits of ED50. J. Pharmacol. Exp. Ther. 96: 99-113.
24. Lozoya X, Enríquez R (1981). El zapote blanco. CONACYT, México, D. F., pp. 17-31.
25. Magos GA, Vidrio H, Reynolds WF, Enríquez RG (1999). Pharmacology of Casimiroa edulis IV. Hypotensive effects of compounds isolated from methanolic extracts in rats and guinea pigs. J. Ethnopharmacol. 64: 35-44.
26. Martínez M (1967). Las plantas medicinales de México. Ediciones Botas. Cuarta edición. México. D.F. pp. 113-115
27. Molina-Hernández M, Téllez-Alcántara NP, Pérez GJ, Olivera-López JI, Jaramillo MT (2004). Anxiolytic-like actions of leaves of Casimiroa edulis (Rutaceae) in male Wistar rats. J. Ethnopharmacol. 93: 93-98.
28. Montenegro M, Veiga H, Deslandes A, Cagy M, McDowell K, Pompeu F, Piedade R, Ribeiro P (2005). Neuromodulatory effects of caffeine and bromazepam on visual event-related potential (P300): a comparative study. Arq. Neuropsiquiatr. 63: 410-415.
29. Mora S, Díaz-Velis G, Lungenstrass H, García GM, Coto-Morales T, Poletti C, de Lima TCM, Herrera-Ruíz M, Tortoriello J (2005). Central nervous system activity of the hydroalcoholic extract of Casimiroa edulis in rat and mice. J. Ethnopharmacol. 97: 93-98.
30. Navarro LA, Bastidas RBE, García EJ, García LP, Garzón P (1995). Anticonvulsivant activity of Casimiroa edulis in comparison to phenytoin and phenobarbital. J. Ethnopharmacol. 45: 199-206.
31. Newman DJ, Cragg GM (2007). Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 70: 461-477.
32. Parra VA, Ramos RA, Villaescusa GA, Betancourt BJ, García LA, Piloto FJ, Décalo MM (2002). Passiflora incarnata L. y Senna alata (L.) Roxo: Estudio toxicogenético que emplea dos sistemas de ensayos a corto plazo. Rev. Cub. Plant Méd. 7: 27-31.
33. Pellow S, Chopin P, File SE, Briley M (1985). Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosc Meth 14:149-167.
34. Pennington TD, Sarukhan J (1998). Árboles tropicales de México. Fondo de Cultura Económica. Segunda Edición. México, D.F. p. 278.
35. Ponce-Monter H, Campos MG, Pérez S, Pérez C, Zavala M, Macías A, Oropeza M, Cárdenas N (2008). Chemical composition and anti-spasmodic effect of Casimiroa pringlei essential oil on rat uters. Fitoterapia 79: 446-450.
36. Puga F, Veiga H, Cagy M, McDowell K, Piedade R, Ribeiro P (2005). Analysis of the influence of bromazepam on cognitive performance through the visual evoked potential (P300). Arq. Neuropsiquiat. 63: 228-234.
37. Sankoh AJ, Huque MF, Dubey SD (1997). Some comments on frequently used multiple endpoint adjustment methods in clinical trials. Stat. Med. 16: 2529-5242.
38. Schmitt U, Hiemke C (1998). Combination of open field and elevated plus-maze: A suitable test battery to asses strain as well as treatment differences in rat behavior. Prog. Neuropsychopharmacol. Psychiatry 22: 1197-1215.
39. Schuck S, Allain H, Gandon JM, Patat A, Millet V, Le Coz F (1998). Effect of bromazepam versus placebo on inhibition and waiting capacity in young women with traits of anxiety. Fundam Clin. Pharmacol. 12: 463-467.
40. Silva RH, Frussa-Filho R (2000). The plus-maze discriminative avoidance task: A new model to study memory-anxiety interactions. Effects of chlordiazepoxide and caffeine. J. Neurosc. Meth. 30: 117-125.
41. Sonavane GS, Sarveiya VP, Kasture VS, Kasture SB (2002). Ansiogenic activity of Myristica fragans seeds. Pharmacol. Bichem. Behav. 71: 239-244.
42. Standley PC (1924). Trees and Shrubs of México. Smithsonian Institution, United States National 23: 820-822.
43. Suárez A, Echandi MM, Ulate G, Cicció JF (2003). Pharmacological activity of the essential oil of Satureja viminea (Laminaceae). Rev. Biol. Trop. 51: 247-252.
44. Takeda H, Tsuji M, Matsumiya T (1998). Changes in head-dipping behavior in the hole board test reflect the anxiogenic and/or anxiolytic state in mice. Eur. J. Pharmacol. 350: 21-29.
45. Vaconcelos SM, Macedo DS, de Melo CT, Paiva-Monteiro A, Rodríguez AC, Silveira ER, Cunha GM, Souza FC, Viana GS (2004). Central activity of hydroalcoholic extracts from Erythrina velutina and Erythrina mulungu in mice. J. Pharm. Pharmacol. 56(3):389-393.
46. Vera-Caletti P, Vibrans H (2002). Uses and management of genus Casimiroa (Rutaceae). Annu. Meet Soc. Ecol. Bot. 43: 44.
47. Wasowski VH, Levi de Stein L, Wolfma Silveira R, Dajas F, Medina JH, Paladini AC (1995). Apigenin, a component of Matricaria recutita flowers, is a central benzodiazepine receptors-ligand with anxiolytic effects. Planta Med. 61: 213-216.
48. A, acetyl-choline and serotonin receptors in the amygdale of seven inbred mouse strains. Behav. Brain Res. 145: 145-159.
49. Zanoli P, Avallone R, Baraldi M (2000). Behavioral characterization of the flavonoids apigenin and chrysin. Fitoterapia 1: 117-123.